MarketFriction

FDC Ltd

NSE FDC · BSE 531599 · Pharmaceuticals
₹335.90 -1.03%
NSE close2026-10-01
52 week range312.95 - 476.40
Market cap₹5,700 Cr.
P/E18.5
Price band 20% Delivery 38.5%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales486458462638514464492648473465585668
Expenses410374406492444417438508439412478525
Operating Profit7684561477047541403452106143
OPM %16%18%12%23%14%10%11%22%7%11%18%21%
Other Income27252028351916362105048
Interest111111111121
Depreciation101010111413161515151415
Profit before tax9398651639051531603836140175
Tax %25%19%29%27%20%28%27%24%26%22%26%24%
Net Profit7079461197237391212828103132
EPS in Rs4.294.872.847.314.422.282.387.451.741.746.358.14
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales9941,0131,0741,0891,3411,3311,5251,7841,9432,1082,1712,190
Expenses7657698418601,0389971,2711,5331,6041,7831,8251,855
Operating Profit229243233229304334254251339325346335
OPM %23%24%22%21%23%25%17%14%17%15%16%15%
Other Income39444542579576501029193118
Interest111133344555
Depreciation343535333738373940545959
Profit before tax232252241237320388289258396357375390
Tax %27%25%28%28%25%22%25%25%23%25%25%
Net Profit169189174170240301216194305267281293
EPS in Rs9.4810.609.959.7414.0317.8512.8211.7018.7516.3917.2917.97
Dividend Payout %24%21%-0%-0%6%-0%-0%-0%-0%31%29%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth8%10%7%3%
Compounded Profit Growth5%-1%12%14%
Stock Price CAGR5%0%-3%-22%
Return on Equity13%12%12%11%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital181818181817171717161616
Reserves9191,0651,2521,2591,4281,5301,7171,9401,9652,0812,2652,469
Borrowings2111115153228212115
Other Liabilities210182197228194250208281333350412418
Total Liabilities1,1481,2661,4681,5051,6401,8131,9562,2702,3432,4682,7142,919
Fixed Assets393675678674682674689705699680852999
CWIP292061312241910519826113796
Investments4893254914715856657908868068431,0281,048
Other Assets237246293348360451458575640684698775
Total Assets1,1481,2661,4681,5051,6401,8131,9562,2702,3432,4682,7142,919
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity128174154150112250207162155221318200
Cash from Investing Activity-89-73-14421-121-98-77-14511-17-199-110
Cash from Financing Activity-48-970-169-0-142-129-10-180-202-92-93
Net Cash Flow-94111-81017-14226-3
Free Cash Flow83-13013011470247148354715122740
CFO/OP96%101%92%94%81%110%90%95%93%96%129%83%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days252327282934302025221926
Inventory Days132134148166184180189210183216186182
Days Payable94848110182101689499103102106
Cash Conversion Cycle64729493131113152135109135103102
Working Capital Days112123294540484548533341
ROCE %21%22%21%19%17%21%22%15%13%18%16%15%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters69.66%69.66%69.66%69.66%69.66%69.66%69.66%69.66%69.66%69.66%69.65%69.65%
FIIs2.42%2.43%2.65%2.51%2.62%2.67%2.56%2.41%2.43%2.32%2.40%1.40%
DIIs8.12%7.76%6.94%6.72%6.02%6.08%6.37%7.17%6.81%6.27%6.29%6.31%
Public19.80%20.15%20.76%21.11%21.71%21.60%21.42%20.76%21.10%21.76%21.65%22.63%
No. of Shareholders56,92855,34152,37750,63455,40055,22853,88054,44554,15753,78852,73055,045

Fundamentals

Market Cap₹ 5,700 Cr.
Current Price₹ 350
Stock P/E18.5
Book Value₹ 153
ROCE15.4 %
ROE11.2 %
Dividend Yield1.43 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)3%
Compounded Profit Growth (TTM)14%
Consolidated figures.
Valuation
Market capRs 5,469 Cr
Enterprise valueRs 5,434 Cr
P/E (TTM)18.69x
Price to book2.20x
Price to sales2.50x
EV / EBITDA11.98x
EV / EBIT13.79x
EV / sales2.48x
Price to cash flow27.28x
Earnings yield5.35%
Dividend yield1.49%
P/E, 3-year average21.76x
P/B, 3-year average2.74x
P/E, 5-year average21.45x
P/B, 5-year average2.52x
Profitability
Operating margin (excl. other income)15.94%
Operating margin (incl. other income)20.21%
EBITDA margin20.71%
Pre-tax margin17.79%
Net profit margin13.36%
Net margin, latest quarter19.84%
ROE11.81%
ROCE15.81%
ROA9.99%
ROE, 3-year average12.99%
ROCE, 3-year average17.19%
ROA, 3-year average10.99%
ROE, 5-year average12.11%
ROCE, 5-year average16.06%
ROA, 5-year average10.33%
ROIC (approx.)12.08%
Tax rate24.87%
Other income / net worth3.73%
Growth
Sales growth (latest year)2.98%
Profit growth (latest year)5.48%
Sales CAGR, 3 years6.77%
Sales CAGR, 5 years10.28%
Profit CAGR, 3 years13.19%
Profit CAGR, 5 years-1.36%
Sales growth QoQ14.18%
Profit growth QoQ28.13%
Sales growth YoY (latest quarter)2.97%
Profit growth YoY (latest quarter)9.17%
Per share
EPS (TTM)Rs 17.97
EPS (latest year)Rs 17.29
EPS (latest quarter)Rs 8.14
EPS, 3-year averageRs 17.47
EPS, 5-year averageRs 15.39
Book value per shareRs 152.64
Sales per shareRs 134.53
Cash flow per shareRs 12.31
Free cash flow per shareRs 2.46
Dividend per share (latest year)Rs 5.00
Dividend per share, 3-year averageRs 5.00
Dividend per share, 5-year averageRs 5.00
Dividends
Dividend payout28.92%
Dividend payout, 3-year average29.72%
Dividend payout, 5-year average29.72%
Efficiency
Asset turnover0.74x
Fixed asset turnover2.17x
Inventory turnover2.59x
Inventory days141 days
Debtor days26 days
Debtors turnover14.31x
Creditor days106 days
Cash conversion cycle102 days
Working capital days41 days
Leverage
Total debtRs 15 Cr
Cash and bankRs 50 Cr
Net debtRs -35 Cr
Debt to equity0.01x
Net debt / EBITDA-0.08x
Interest coverage84.77x
Current ratio (filing 2026-03-31)3.11x
Quick ratio (filing 2026-03-31)2.13x
Trade payables (filing 2026-03-31)Rs 207 Cr
Owners' fund to total sources85.14%
Debt to assets0.53%
Cash flow
Cash from Operating Activity (latest year)Rs 200 Cr
Cash from Investing Activity (latest year)Rs -110 Cr
Cash from Financing Activity (latest year)Rs -93 Cr
Net Cash Flow (latest year)Rs -3 Cr
Free cash flow (latest year)Rs 40 Cr
FCFE (approx.: FCF + change in debt)Rs 34 Cr
Cash from ops / profit, 5 years0.84x
Sales to cash flow10.83x
Statement figures
Net sales (TTM)Rs 2,190 Cr
Net sales (latest year)Rs 2,171 Cr
Sales (latest quarter)Rs 668 Cr
Operating profit excl. other income (latest year)Rs 346 Cr
Operating profit (latest quarter)Rs 143 Cr
Other income (TTM)Rs 118 Cr
EBITDA (TTM)Rs 454 Cr
PBDT (TTM)Rs 449 Cr
Profit before tax (TTM)Rs 390 Cr
Tax (latest year)Rs 93 Cr
Net profit (TTM)Rs 293 Cr
Net profit (latest year)Rs 281 Cr
Net profit (latest quarter)Rs 132 Cr
Depreciation (TTM)Rs 59 Cr
Depreciation (latest quarter)Rs 15 Cr
Interest (TTM)Rs 5 Cr
Cost of goods sold (latest year)Rs 921 Cr
Total expenditure (latest year)Rs 1,825 Cr
Total income (latest year)Rs 2,264 Cr
Share capitalRs 16 Cr
ReservesRs 2,469 Cr
Shareholders' fundsRs 2,485 Cr
Total assetsRs 2,919 Cr
Net blockRs 999 Cr
Capital work in progressRs 96 Cr
InvestmentsRs 1,048 Cr
ReceivablesRs 152 Cr
InventoryRs 355 Cr
Other liabilitiesRs 418 Cr
Shares outstanding (crore)16.28
Ownership
Promoter holding69.65% (-0.01 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 18.7 is at the 26th percentile of its own 9.4-year range (median 21.4, low 13.3, high 38.0).
P/B 2.20 is at the 12th percentile (median 2.86).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodFDCNifty 50Difference
1 week-2.8%-2.8% -0.1 pts
1 month+0.7%-6.8% +7.5 pts
3 months-22.6%-7.6% -15.0 pts
6 months+4.6%+0.4% +4.2 pts
1 year-27.6%-9.9% -17.7 pts
2 years-40.4%-13.6% -26.8 pts
3 years-12.4%+14.2% -26.6 pts
5 years-3.0%+27.9% -30.9 pts
13 mutual fund schemes hold about ₹409 Cr. Over three months 3 bought more and 4 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Nippon India Small Cap Fund0.17%144 -3%
ICICI Pru Small Cap Fund0.57%56 -6%
ICICI Pru Small Cap Fund0.57%54 -6%
ICICI Pru Healthcare Fund-0.62%43 +2%
Tata India Pharma & Healthcare Fund2.10%32 +16%
ICICI Pru ESG Exclusionary Strategy Fund1.64%22 +2%
ICICI Pru Retirement Fund-Pure Equity Plan0.86%19 +106%
ICICI Pru MNC Fund0.91%16 -0%
Bandhan Small Cap Fund0.04%15 -14%
ICICI Pru Bharat Consumption Fund0.11%4 -36%
Titanium Equity Long-Short Fund1.46%3 +100%
Bandhan BSE Healthcare Index Fund0.10%0 -2%
Motilal Oswal BSE 1000 Index Fund0.01%0 +3%

Red flags

F-score 5 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹668 Cr +3.1% vs Jun 2025. Net profit ₹132 Cr +9.1%.
Against our estimate for Jun 2026: sales -5.9%, profit +57.4% beat. Our estimate for Sep 2026: sales Rs 525 Cr, profit Rs 62 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Sun Pharmaceutical Industries Ltd447,47635.420.5 %
Divis Laboratories Ltd250,36384.022.0 %
Torrent Pharmaceuticals Ltd186,15283.415.2 %
Zydus Lifesciences Ltd119,75024.621.1 %
Cipla Ltd111,43031.115.5 %
Laurus Labs Ltd106,92897.817.8 %
Mankind Pharma Ltd105,12049.313.5 %
Dr Reddys Laboratories Ltd104,49432.413.0 %
Aurobindo Pharma Ltd97,68225.812.9 %
Lupin Ltd93,84015.829.9 %
Glenmark Pharmaceuticals Ltd68,90522.139.8 %
Alkem Laboratories Ltd62,77227.621.2 %
Biocon Ltd61,43984.53.61 %
Abbott India Ltd57,94935.944.8 %
Gland Pharma Ltd49,33343.115.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-02-11Interim Dividend - Rs 5 Per Share
2024-11-22Interim Dividend - Rs 5 Per Share
2024-09-19Annual General Meeting
2023-09-20Annual General Meeting
2023-08-25Buy Back
2022-09-13Annual General Meeting
2022-02-17Buy Back
2021-09-20 Annual General Meeting
2020-09-22 Annual General Meeting
2020-08-20 Buyback
2020-03-19 Interim Dividend - Rs 0.80 Per Share
2019-09-19 Annual General Meeting
2019-06-06 Buyback
2018-08-30 Annual General Meeting
2018-02-26 Buyback
2017-08-08 Annual General Meeting/Dividend - Rs 2.25 Per Share
2016-09-06 Annual General Meeting
2016-03-17 Interim Dividend - Rs 2.25/- Per Share
2015-09-23 Annual General Meeting/ Dividend - Rs 2.25/- Per Share
2014-07-28Annual General Meeting/Dividend Rs 2.25/- Per Share
2013-08-20Annual General Meeting / Dividend - Rs 2.25/- Per Share
2012-08-06Annual General Meeting And Dividend Rs.2/- Per Share
2011-09-13Annual General Meeting And Dividend Rs.2/- Per Share
2010-08-10Annual General Meeting And Dividend Rs.1.75 Per Share
2009-08-17Agm/Div-Rs.1.25 Per Share
2008-08-18Agm/Dividend - 100%
2007-08-13Agm
2007-03-15Interim Dividend-100% Purpose Revised
2006-09-05Agm/Final Dividend-30%
DateTypeWhat it says
2026-09-24Shareholder meetingFDC Limited has submitted the Exchange a copy of Voting results and Scrutinizers report of 86th Annual General Meeting held on September 24, 2026.
2026-09-24Shareholder meetingProceedings of Annual General Meeting held on September 24, 2026
2026-09-17CorrigendumCorrigendum to Notice of Annual General Meeting to be held on September 24, 2026
2026-09-01Record DateRecord date for the purpose of Meeting is 16-Sep-2026.
2026-09-01Shareholder meetingNotice of Annual General Meeting to be held on September 24, 2026
2026-08-27General UpdatesInterim Stay received from The Honourable High Court of Delhi, New Delhi
2026-08-13General UpdatesMarketing Authorisation received by its subsidiary, FDC International Ltd, from MHRA, UK, for Atropine 1.0% w/v Eye Drops, Solution.
2026-08-05Press ReleaseA press release dated August 05, 2026, titled "Press Release Q1 FY 2026-2027 Results".
2026-08-05Board meeting outcomeFDC Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-06-04General UpdatesGeneral Updates
2026-05-28Shareholder meetingVoting results.
2026-05-28Press Release (Revised)FDC Limited has resubmitted press release dated May 27, 2026, titled "Press Release on Q4 - FY 2025-26 and 12M - FY 2025-26 Results".
2026-05-27Press ReleaseA press release dated May 27, 2026, titled "Financial Results".
2026-05-27Board meeting outcomeOutcome of Board Meeting held on May 27, 2026.
2026-05-27Board meeting outcomeFDC Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-05-18General UpdatesGeneral Updates
2026-05-09Shareholder meetingNotice of Postal Ballot
2026-05-07Disclosure under SEBI TakeovFDC Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acqui...
2026-04-24UpdatesFDC Limited has informed the Exchange regarding Confirmation regarding the Company not falling under Large Corporate criteria as on March 31, 2026..
2026-04-22Shareholder meetingNotice of Postal Ballot
2026-04-21General UpdatesThe Board of Directors have approved seeking Shareholders Approval through Postal Ballot Process in relation to appointment of Mr. Kishore Saletore as...
2026-03-20UpdatesGeneral Update.
2026-03-18Director changeChange in Director(s) of the company.
2026-02-19Disclosure under SEBI TakeovAditi Bhanot has submitted to the Exchange a copy of Disclosures under Regulation 10(5)-Report to stock Exchange in respect of any acquisition made in...
2026-02-19Disclosure under SEBI TakeovAditi Bhanot has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in...
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of FDC Ltd?

FDC Ltd (FDC) has a market capitalisation of Rs 5,700 Cr. at the 2026-10-01 close.

What is the P/E ratio of FDC Ltd?

FDC Ltd trades at a P/E of 18.5 on trailing twelve-month profit, at the 2026-10-01 close.

What were FDC Ltd's latest quarterly results?

In the Jun 2026 quarter, FDC Ltd sales was Rs 668 Cr (+3.1% vs Jun 2025) and net profit was Rs 132 Cr.

What is the 52-week high and low of FDC Ltd?

The 52-week high is Rs 476.40 and the 52-week low is Rs 312.95.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03